Autologous bone marrow-derived stem cells labeled with F18-FDG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous bone marrow-derived stem cells labeled with F18-FDG, covering 2012-10-01 to 2012-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM [Phase 2, Phase 3]